Moreover, CCR5 is recruited at the immune synapse formed between T cells and tumor target cells upon interaction of CD103 with E-cadherin, promoting retention of TRM cells at the tumor site by inhibiting their sensitivity to a CCL5 chemotactic gradient (7). This evidence concerns the gene CDH1 and neoplasm.